Ownership and insider activity for SI-BONE, Inc. (SIBN): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally.
Price
| Price | $18.54 |
| Market Cap | $822M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-01 | DUNN JEFFREY W | M-Exempt | 1,367 | $6K |
| 2026-09-01 | DUNN JEFFREY W | M-Exempt | 18,633 | $87K |
| 2026-09-01 | DUNN JEFFREY W | M-Exempt | 1,367 | $6K |
| 2026-09-01 | DUNN JEFFREY W | M-Exempt | 18,633 | $87K |
| 2026-09-01 | DUNN JEFFREY W | S-Sale | 18,633 | $352K |
| 2026-09-01 | DUNN JEFFREY W | S-Sale | 1,367 | $26K |
| 2026-08-24 | FRANCIS LAURA | S-Sale | 25,972 | $523K |
| 2026-08-24 | Maheshwari Anshul | S-Sale | 11,636 | $234K |
| 2026-08-20 | FRANCIS LAURA | S-Sale | 51,884 | $1.0M |
| 2026-08-21 | FRANCIS LAURA | S-Sale | 3,923 | $79K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27.9M | $22.4M | $25.1M | $10.4M | $53.6M | $63.4M | $20.7M | $33.3M | $34.9M | $42.2M |
| Short-term Investments | 0 | 0 | $97.1M | $81.3M | $142.9M | $83.6M | $76.6M | $132.7M | $115.1M | $105.6M |
| Receivables | $6.0M | $7.4M | $8.5M | $11.7M | $13.6M | $14.2M | $20.7M | $22.0M | $27.5M | $29.9M |
| Inventory | $1.5M | $2.6M | $3.3M | $5.5M | $5.6M | $11.5M | $17.3M | $20.2M | $27.1M | $33.9M |
| Total Current Assets | $36.3M | $33.6M | $136.0M | $111.5M | $218.2M | $175.9M | $137.6M | $211.4M | $207.8M | $216.1M |
| Property, Plant & Equipment | $2.6M | $1.9M | $2.2M | $4.0M | $4.5M | $14.2M | $19.6M | $18.7M | $22.4M | $22.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $47000 | $7.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $39.4M | $35.8M | $138.5M | $117.0M | $223.1M | $190.5M | $157.6M | $230.4M | $230.4M | $238.6M |
| Accounts Payable | $1.0M | $1.8M | $2.1M | $2.8M | $3.3M | $3.2M | $6.3M | $4.6M | $6.5M | $4.6M |
| Short-term Debt | $8.2M | 0 | 0 | $4.4M | 0 | 0 | 0 | 0 | 0 | $944000 |
| Total Current Liabilities | $13.4M | $7.5M | $9.0M | $18.8M | $13.5M | $16.9M | $21.2M | $23.5M | $27.1M | $25.3M |
| Long-term Debt | $21.1M | $38.7M | $39.0M | $34.9M | $39.5M | $35.0M | $35.2M | $36.1M | $35.5M | $175000 |
| Total Liabilities | $148.2M | $165.2M | $48.3M | $54.0M | $53.8M | $56.1M | $59.2M | $61.0M | $63.5M | $61.0M |
| Retained Earnings | -$116.7M | -$139.7M | -$157.2M | -$195.6M | -$239.3M | -$295.8M | -$357.1M | -$400.4M | -$431.4M | -$450.3M |
| Total Equity | -$108.7M | -$129.4M | $90.2M | $63.0M | $169.4M | $134.4M | $98.3M | $169.4M | $167.0M | $177.5M |
| Total Debt | $29.3M | $38.7M | $39.0M | $39.2M | $39.5M | $40.5M | $39.4M | $39.0M | $37.5M | $1.1M |
| Net Debt | $1.4M | $16.3M | -$83.3M | -$52.6M | -$157.0M | -$106.5M | -$57.9M | -$127.0M | -$112.6M | -$146.7M |
| Working Capital | $22.9M | $26.1M | $127.0M | $92.7M | $204.8M | $159.0M | $116.4M | $187.9M | $180.6M | $190.8M |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 9.15 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 7.29 |
Profitability
| Return on Equity | -8.23% |
| Return on Invested Capital | -7.88% |
| Return on Assets | -5.88% |
| Gross Margin | 79.53% |
| Operating Margin | -8.31% |
| Net Margin | -6.85% |
Related companies: AIRS · AQST · AVNS · AVXL · BFLY · CLPT · INNV
Explore sector: Healthcare · Medical - Devices
More sections of SIBN: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks